29 related articles for article (PubMed ID: 2464752)
1. Regulation of the mdm2 oncogene by thyroid hormone receptor.
Qi JS; Yuan Y; Desai-Yajnik V; Samuels HH
Mol Cell Biol; 1999 Jan; 19(1):864-72. PubMed ID: 9858609
[TBL] [Abstract][Full Text] [Related]
2. Detection of a new de novo mutation at codon 251 of exon 8 of thyroid hormone receptor beta gene in an Italian kindred with resistance to thyroid hormone.
Macchia E; Agostini M; Sarkissian G; Giorgilli G; Canale D; Scartabelli G; Margotat A; Torresani J; Pinchera A
J Endocrinol Invest; 1998 Apr; 21(4):226-33. PubMed ID: 9624596
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression.
Qi JS; Desai-Yajnik V; Yuan Y; Samuels HH
Mol Cell Biol; 1997 Dec; 17(12):7195-207. PubMed ID: 9372952
[TBL] [Abstract][Full Text] [Related]
4. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.
Au-Fliegner M; Helmer E; Casanova J; Raaka BM; Samuels HH
Mol Cell Biol; 1993 Sep; 13(9):5725-37. PubMed ID: 8395010
[TBL] [Abstract][Full Text] [Related]
5. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor.
Casanova J; Helmer E; Selmi-Ruby S; Qi JS; Au-Fliegner M; Desai-Yajnik V; Koudinova N; Yarm F; Raaka BM; Samuels HH
Mol Cell Biol; 1994 Sep; 14(9):5756-65. PubMed ID: 8065310
[TBL] [Abstract][Full Text] [Related]
6. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
Qi JS; Desai-Yajnik V; Greene ME; Raaka BM; Samuels HH
Mol Cell Biol; 1995 Mar; 15(3):1817-25. PubMed ID: 7862171
[TBL] [Abstract][Full Text] [Related]
7. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of thyroid hormone action.
DeGroot LJ; Nakai A; Sakurai A; Macchia E
J Endocrinol Invest; 1989 Dec; 12(11):843-61. PubMed ID: 2693518
[No Abstract] [Full Text] [Related]
9. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.
Usala SJ; Tennyson GE; Bale AE; Lash RW; Gesundheit N; Wondisford FE; Accili D; Hauser P; Weintraub BD
J Clin Invest; 1990 Jan; 85(1):93-100. PubMed ID: 2153155
[TBL] [Abstract][Full Text] [Related]
10. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
de Verneuil H; Metzger D
Nucleic Acids Res; 1990 Aug; 18(15):4489-97. PubMed ID: 1975094
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.
Bonde BG; Sharif M; Privalsky ML
J Virol; 1991 Apr; 65(4):2037-46. PubMed ID: 1672166
[TBL] [Abstract][Full Text] [Related]
12. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.
Parrilla R; Mixson AJ; McPherson JA; McClaskey JH; Weintraub BD
J Clin Invest; 1991 Dec; 88(6):2123-30. PubMed ID: 1661299
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the domain structure of chick c-erbA by deletion mutation: in vitro translation and cell transfection studies.
Horowitz ZD; Yang CR; Forman BM; Casanova J; Samuels HH
Mol Endocrinol; 1989 Jan; 3(1):148-56. PubMed ID: 2464752
[TBL] [Abstract][Full Text] [Related]
14. The c-erbA alpha-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase II.
Glineur C; Bailly M; Ghysdael J
Oncogene; 1989 Oct; 4(10):1247-54. PubMed ID: 2552374
[TBL] [Abstract][Full Text] [Related]
15. c-erbA protooncogenes mediate thyroid hormone-dependent and independent regulation of the rat growth hormone and prolactin genes.
Forman BM; Yang CR; Stanley F; Casanova J; Samuels HH
Mol Endocrinol; 1988 Oct; 2(10):902-11. PubMed ID: 2903439
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.
Bigler J; Hokanson W; Eisenman RN
Mol Cell Biol; 1992 May; 12(5):2406-17. PubMed ID: 1314955
[TBL] [Abstract][Full Text] [Related]
17. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone action and the erbA oncogene family.
Goldberg Y; Glineur C; Bosselut R; Ghysdael J
Biochimie; 1989 Feb; 71(2):279-91. PubMed ID: 2539867
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
